Effect of Short-term Oxygen During CPET in COPD
Effect of Short-term Oxygen Therapy on Cardiopulmonary Exercise (CPET) Capacity in Patients With Chronic Obstructive Pulmonary Disease (COPD)
1 other identifier
interventional
20
1 country
1
Brief Summary
In a randomized, sham-controlled trial the investigators will test whether supplemental oxygen given during cardiopulmonary exercise testing will improve exercise performance and physiological parameters in patients with chronic obstructive pulmonary disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_2 chronic-obstructive-pulmonary-disease
Started Jun 2017
Typical duration for phase_2 chronic-obstructive-pulmonary-disease
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 2, 2017
CompletedFirst Submitted
Initial submission to the registry
June 20, 2017
CompletedFirst Posted
Study publicly available on registry
June 22, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2018
CompletedAugust 13, 2019
August 1, 2019
1.6 years
June 20, 2017
August 12, 2019
Conditions
Outcome Measures
Primary Outcomes (2)
Watt
1 day
Exercise time
1 day
Secondary Outcomes (5)
Peak Oxygen uptake
1 day
Respiratory Exchange ratio
1 day
Ventilatory equivalent of carbon dioxide (VE/VCO2) slope
1 day
End-tidal pressures of carbon dioxide (PET CO2)
1 day
Changes in arterial blood parameters
1 day
Study Arms (2)
Supplemental oxygen
EXPERIMENTALSupplemental oxygen will be applied via a mask during CPET
Sham room air
SHAM COMPARATORRoom air will be applied similarly to oxygen
Interventions
Eligibility Criteria
You may qualify if:
- diagnosis of chronic obstructive pulmonary disease
- on optimized medical therapy and in stable condition for at least 4 week
- desaturate in the 6 minute walking test by at least 4% to values \<92%
You may not qualify if:
- unstable conditions
- pregnant women
- patients with relevant concomitant lung disease and severe daytime hypoxemia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital Zurich, Division of Pneumology
Zurich, 8091, Switzerland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Silvia Ulrich Somaini, Prof. Dr.
University Hospital Zurich, Division of Pneumology
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 20, 2017
First Posted
June 22, 2017
Study Start
June 2, 2017
Primary Completion
December 31, 2018
Study Completion
December 31, 2018
Last Updated
August 13, 2019
Record last verified: 2019-08
Data Sharing
- IPD Sharing
- Will not share